Thomas Kassberg
2019
In 2019, Thomas Kassberg earned a total compensation of $2.5M as Chief Business Officer and Executive Vice President at Ultragenyx Pharmaceutical, a 45% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $206,901 |
|---|---|
| Option Awards | $863,513 |
| Salary | $474,000 |
| Stock Awards | $878,150 |
| Other | $33,937 |
| Total | $2,456,501 |
Kassberg received $878.2K in stock awards, accounting for 36% of the total pay in 2019.
Kassberg also received $206.9K in non-equity incentive plan, $863.5K in option awards, $474K in salary and $33.9K in other compensation.
Rankings
In 2019, Thomas Kassberg's compensation ranked 4,942nd out of 13,971 executives tracked by ExecPay. In other words, Kassberg earned more than 64.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,942 out of 13,971 | 65th |
Division Manufacturing | 1,841 out of 5,701 | 68th |
Major group Chemicals And Allied Products | 649 out of 2,200 | 71st |
Industry group Drugs | 548 out of 1,886 | 71st |
Industry Pharmaceutical Preparations | 411 out of 1,398 | 71st |
Source: SEC filing on April 29, 2020.
Kassberg's colleagues
We found four more compensation records of executives who worked with Thomas Kassberg at Ultragenyx Pharmaceutical in 2019.
2019
Emil Kakkis
Ultragenyx Pharmaceutical
Chief Executive Officer
2019
John Pinion
Ultragenyx Pharmaceutical
Chief Quality Officer and Executive Vice President, Translational Sciences
2019
Shalini Sharp
Ultragenyx Pharmaceutical
Chief Financial Officer
2019
Camille Bedrosian
Ultragenyx Pharmaceutical